Announcements Trials
Browse Landscape

Phase

Phase 2 76Phase NA 30Phase 3 25Phase 1 13Phase 2/3 7Phase 1/2 6Phase EARLY_PHASE1 5Phase 4 1

Status

Recruiting 2Active not recruiting 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gynecologic 2Head & Neck 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Neoplasm Metastasis 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1

Interventions

pembrolizumab 212Cyclophosphamide 120Nivolumab 110Carboplatin 92fludarabine 79Gemcitabine 79Specimen Handling 74Bevacizumab 73venetoclax 70Injections 70Magnetic Resonance Spectroscopy 68Paclitaxel 66Dexamethasone 66Biopsy 59atezolizumab 56Cisplatin 54Ipilimumab 49Temozolomide 45Lenalidomide 43Docetaxel 43Azacitidine 43Pemetrexed 42Rituximab 41Oxaliplatin 40Fluorouracil 40Radiotherapy 39Cetuximab 39durvalumab 37Cytarabine 36Capecitabine 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1/2 × Surgical Procedures, Operative × 1 year × Clear all
NCT06307548 2026-05-06

Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer

Roswell Park Cancer Institute

Phase 1/2 Recruiting
21 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT06097468 2026-04-13

Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)

University of California, San Francisco

Phase 1/2 Recruiting
40 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT05081609 2026-02-24

IL Believe

Ascendis Pharma A/S

Phase 1/2 Active not recruiting
320 enrolled
Gynecologic

Uterine Cervical Neoplasms, Neoplasm Metastasis

NCT06305767 2026-01-13

INTerpath-005

Merck Sharp & Dohme LLC

Phase 1/2 Active not recruiting
230 enrolled
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Urinary Bladder Neoplasms

NCT02807597 2025-08-17

Real-time Intraoperative Breast Cancer Visualization for Margin Assessment

University of Texas Southwestern Medical Center

Phase 1/2 Terminated
9 enrolled 5 charts
Breast

Breast Neoplasms

NCT06602063 2025-06-27

Surgery for Relapsed Ovarian Cancer in Precision

Shanghai Gynecologic Oncology Group

Phase 1/2 Not yet recruiting
33 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡